Nymox Pharmaceutical Corp Beta
Qual é o Beta de Nymox Pharmaceutical Corp?
O Beta de Nymox Pharmaceutical Corp é 0.00
Qual é a definição de Beta?
BETA indica se uma ação é mais ou menos volátil do que o mercado como um todo. Um beta menor que 1 indica que o estoque é menos volátil do que o mercado, enquanto um beta maior que 1 indica que o estoque é mais volátil. A volatilidade é medida como a flutuação do preço em torno da média.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de empresas na Setor Health Care em NASDAQ em comparação com Nymox Pharmaceutical Corp
O que Nymox Pharmaceutical Corp faz?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Empresas com beta semelhantes a Nymox Pharmaceutical Corp
- Vision Marine Technologies tem Beta de 0.00
- Ely Gold Royalties tem Beta de 0.00
- Glacier Lake Resources tem Beta de 0.00
- Magnum Mining and Exploration tem Beta de 0.00
- Africa Opportunity Fund tem Beta de 0.00
- Fulcrum Utility Services tem Beta de 0.00
- Nymox Pharmaceutical Corp tem Beta de 0.00
- Gullewa tem Beta de 0.00
- S.A.L. Steel tem Beta de 0.00
- Andina Acquisition III tem Beta de 0.00
- Andina Acquisition III tem Beta de 0.00
- Brilliant Acquisition tem Beta de 0.00
- Indokem tem Beta de 0.00